Drug Trial Radar · NCT04571060
Randomized Trial in Adult Participants With Acute Migraines
Last checked: Nov 20, 2026Latest source record: Apr 24, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,978
Actual
Start
Oct 27, 2020
Primary completion
Oct 10, 2021
Study completion Oct 22, 2021
Sponsor
- Lead sponsor
- PfizerPfizer (PFE)
- Sponsor type
- Industry
- First posted
- Sep 30, 2020
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to test the safety and efficacy of BHV-3500 (zavegepant) versus placebo in the acute treatment of moderate or severe migraine.
Conditions
- Migraine
Interventions
ZavegepantDrug
One dose of zavegepant
PlaceboDrug
One dose of matching placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants With Freedom From Pain at 2 Hours Post-doseTime frame: 2 hours post-dose
- Percentage of Participants With Freedom From Most Bothersome Symptom (MBS) at 2 Hours Post-doseTime frame: 2 hours post-dose
Locations
94 sites in 1 country. Site status is shown where the registry gives one.
Medical Affiliated Research Center
Huntsville, Alabama
Coastal Clinical Research, LLC, An AMR Co.
Mobile, Alabama
MD First Research
Chandler, Arizona
Tucson Neuroscience Research
Tucson, Arizona
Baptist Health Center for Clinical Research
Little Rock, Arkansas
Axiom Research, LLC
Colton, California
Pharmacology Research Institute
Encino, California
eStudySite
La Mesa, California
Synergy San Diego
Lemon Grove, California
Collaborative Neuroscience Network, LLC
Long Beach, California
Pharmacology Research Institute
Los Alamitos, California
Clinical Research Institute
Los Angeles, California
Wr-Pri, Llc
Newport Beach, California
Artemis Institute for Clinical Research
Riverside, California
Artemis Institute for Clinical Research
San Diego, California
California Neuroscience Research Medical Group, Inc.
Sherman Oaks, California
CT Clinical Research
Cromwell, Connecticut
Ki Health Partners, LLC dba New England Institute for Clinical Research
Stamford, Connecticut
Neurology Offices of South Florida
Boca Raton, Florida
Clinical Neuroscience Solutions, Inc.
Jacksonville, Florida
Multi-Specialty Research Associates, Inc.
Lake City, Florida
Meridien Research
Lake Mary, Florida
AppleMed Research Group, LLC
Miami, Florida
The Neurology Research Group
Miami, Florida
Clinical Neuroscience Solutions, Inc.
Orlando, Florida
Clinical Neuroscience Solutions, Inc.
Orlando, Florida
Complete Health Research
Ormond Beach, Florida
Ideal Clinical Research
Pembroke Pines, Florida
Clinical Research Center of Florida
Pompano Beach, Florida
Clin-Med Research & Development, LLC
South Miami, Florida
ForCare Clinical Research
Tampa, Florida
JSV Clinical Research Study, Inc.
Tampa, Florida
iResearch Atlanta, LLC
Decatur, Georgia
Meridian Clinical Research, LLC
Savannah, Georgia
Northwest Clinical Trials Inc.
Boise, Idaho
Cedar Crosse Research Center
Chicago, Illinois
Healthcare Research Network II, LLC
Flossmoor, Illinois
Fort Wayne Neurological Center
Fort Wayne, Indiana
Collective Medical Research
Prairie Village, Kansas
Alliance for Multispecialty Research, LLC
Wichita, Kansas
Showing 40 of 94 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.